文献速递妇科

整合患者因素、可切除性评分与手术复杂性预测晚期卵巢癌肿瘤细胞减灭术结局并指导治疗方案的预测模型

Integrated prediction model of patient factors, resectability scores and surgical complexity to predict cytoreductive outcome and guide treatment plan in advanced ovarian cancer.
PubMed 文献 · Gynecol Oncol · 2022-07-09

该研究基于2018年10月至2020年10月纳入的185例晚期上皮性卵巢癌患者,前瞻性记录患者因素、手术可切除性评分和手术复杂性评分,建立整合预测模型(IPM)预测初次肿瘤细胞减灭术(PCS)理想减灭结局,并回顾性分析模型性能。模型将不可切除IVb期、患者因素>2、可切除性评分>5和手术复杂性评分>9的患者分诊至新辅助化疗(NACT),预测理想减灭的敏感性85%、特异性75%、准确性85%。作者认为该算法在进一步验证后可用于分诊患者至PCS或NACT。

要点

  • IPM模型分诊至NACT预测理想减灭(残留病灶<1 cm)的敏感性85%、特异性75%、准确性85%。
  • PCS组患者因素中位数0 vs NACT组2(p<0.01),可切除性评分2 vs 4(p<0.01),术前手术复杂性评分6 vs 8.5(p=0.01)。
  • PCS组88%达到理想减灭,34.5%发生3-4级术后并发症;模型可使3/10例次理想减灭患者改善分诊至NACT。

核心结论

  • 四步IPM算法预测理想减灭具有高敏感性和特异性,并发症可接受且不延误辅助治疗;作者认为该算法在进一步验证后可用于分诊患者至PCS或NACT。

研究设计与样本

  • 2018年10月至2020年10月纳入185例晚期上皮性卵巢癌患者进入专门项目,基于多学科共识决定PCS或NACT,前瞻性记录不可切除IVb期、患者因素、手术可切除性评分和手术复杂性评分数据,建立IPM预测理想减灭结局,并进行回顾性分析评估模型性能。

主要发现

  • 185例 eligible 患者中,81例接受PCS,104例接受NACT。
  • PCS组患者因素中位数0 vs NACT组2(p<0.01),可切除性评分中位数2 vs 4(p<0.01),术前手术复杂性评分中位数6 vs 8.5(p=0.01)。
  • PCS组中88%达到理想减灭,34.5%发生3-4级术后并发症。
  • 模型将不可切除IVb期、患者因素>2、可切除性评分>5和手术复杂性评分>9的患者分诊至NACT,预测理想减灭的敏感性85%、特异性75%、准确性85%。
  • 模型可使3/10例次理想减灭患者改善分诊至NACT;预测无肉眼残留(残留病灶=0 mm)时,相同 cut-offs 的敏感性和特异性分别为85%和76%。

关键数值与推荐

  • IPM算法分诊至NACT的 cut-offs:不可切除IVb期、患者因素>2、可切除性评分>5、手术复杂性评分>9。
  • 预测理想减灭(残留病灶<1 cm)的敏感性85%、特异性75%、准确性85%。
  • 预测无肉眼残留(残留病灶=0 mm)的敏感性85%、特异性76%。

临床怎么用

  • 作者认为该算法在进一步验证后可用于分诊患者至PCS或NACT。

局限性

  • 原文未报告局限性。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

OBJECTIVE: To report performance of an integrated predictive model (IPM) algorithm based on patient factors, surgical resectability and surgical complexity to predict outcome of primary cytoreductive surgery (PCS) and guide treatment plan in patients with advanced epithelial ovarian cancer (AEOC). METHODS: Patients with AEOC between October 2018 and October 2020 were enrolled into a dedicated AEOC program and decision for PCS or neoadjuvant chemotherapy (NACT) was based on multidisciplinary consensus. Data of unresectable stage IVb, patient factors (PF), surgical resectability scores (SRS) and surgical complexity scores (SCS) was prospectively documented. An integrated prediction model (IPM) was developed to predict outcome of optimal (RD < 1 cm) cytoreduction. Retrospective analysis was performed to assess the performance of the IPM. Cut-offs were selected using the Youden Index. RESULTS: Of 185 eligible patients, 81 underwent PCS and 104 were treated with NACT. Patients undergoing PCS had significantly lower median PF (0 vs 2, p < 0.01), SRS (2 vs 4, p < 0.01) and pre-operative SCS (6 vs 8.5, p = 0.01) compared to NACT. In patients undergoing PCS, 88% had optimal cytoreduction and 34.5% had grade 3-4 post-operative complications. A model triaging patients with unresectable Stage IVb, PF > 2, SRS > 5 and SCS > 9 to NACT had 85% sensitivity, 75% specificity and 85% accuracy for outcome of optimal cytoreduction. Our model would have improved triage of 3/10 sub-optimally cytoreduced patients to NACT. For outcome of no-gross residual disease (RD = 0 mm) using the same cut-offs sensitivity and specificity were 85% and 76% respectively. CONCLUSION: The 4-step IPM algorithm had high sensitivity and specificity for optimal cytoreduction with acceptable morbidity without delay to adjuvant therapy. This algorithm may be used to triage patients to PCS or NACT once it is further validated.

来源:Gynecol Oncol,查看原文。版权归原作者所有。

引用

  1. Piedimonte S, Bernardini MQ, Ding A, et al. Integrated prediction model of patient factors, resectability scores and surgical complexity to predict cytoreductive outcome and guide treatment plan in advanced ovarian cancer. Gynecol Oncol. 2022. PMID: 35820987. doi:10.1016/j.ygyno.2022.06.026

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。